Monsenso A/S (CPH:MONSO)
0.2520
-0.0180 (-6.67%)
Sep 11, 2026, 1:00 PM CET
Monsenso Revenue
Monsenso had revenue of 3.33M DKK in the half year ending June 30, 2026, a decrease of -39.77%. This brings the company's revenue in the last twelve months to 7.07M, down -34.56% year-over-year. In the year 2025, Monsenso had annual revenue of 8.91M, down -20.22%.
Revenue (ttm)
7.07M
Revenue Growth
-34.56%
P/S Ratio
3.66
Revenue / Employee
785.56K
Employees
9
Market Cap
25.89M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.91M | -2.26M | -20.22% |
| Dec 31, 2024 | 11.17M | 1.54M | 16.01% |
| Dec 31, 2023 | 9.62M | 3.41M | 54.90% |
| Dec 31, 2022 | 6.21M | -930.00K | -13.02% |
| Dec 31, 2021 | 7.14M | -1.92M | -21.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 329.43B |
| Coloplast | 28.44B |
| Genmab | 27.03B |
| Demant | 24.63B |
| Gubra | 271.02M |
| Scandinavian Medical Solutions | 214.99M |
| BioPorto | 38.37M |
| Stenocare | 11.52M |
Monsenso News
- 14 days ago - Monsenso Quarterly report: H1 2026 - Filings
- 6 months ago - Monsenso Annual report: H2 2025 - Filings